Redefining the value of hormonal therapy in endometrial cancer in the era of molecular classification
Endometrial cancer is one of the most common gynecological cancers,with an annually increasing inci-dence rate and a trend of harassing younger women than before.The introduction of molecular classification has over-come the limitations of the traditional Bokhman division,facilitating precise diagnosis,risk stratification,and targeted therapy of endometrial cancer by exploring molecular features.In the era of molecular classification,hormone therapy,as a traditional treatment characterized by low toxicity,high cost-effectiveness,and high patient compliance,should be redefined for the value.
万方数据
维普
